Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Cicalini

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Antibiotics (Basel, Switzerland)|March 28, 2025
Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare SettingAssunta Navarra, Stefania Cicalini, Silvia D'Arezzo, et al.
The New Microbiologica|May 2, 2025
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics)Sara Tordi, Elena Ricci, Luca Mezzadri, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Surveillance and Characterization of Vancomycin-Resistant and Vancomycin-Variable Enterococci in a Hospital SettingClaudia Rotondo, Valentina Antonelli, Alberto Rossi, et al.
Travel Medicine and Infectious Disease|September 21, 2024
Dengue fever as autochthonous infectious disease in Italy: Epidemiological, clinical and virological characteristicsSerena Vita, Eleonora Lalle, Priscilla Caputi, et al.
Atherosclerosis|May 20, 2017
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohortPaolo Maggi, Chiara Bellacosa, Armando Leone, et al.
Journal of Fungi (Basel, Switzerland)|September 26, 2025
Pulmonary Aspergillosis in Immunocompromised Critically Ill Patients: Prevalence, Risk Factors, Clinical Features and Diagnosis-A Narrative ReviewMaria Grazia Bocci, Laura Cascarano, Giulia Capecchi, et al.
Journal of Clinical Microbiology|July 3, 2015
Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level ViremiaLavinia Fabeni, Giulia Berno, Valentina Svicher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIVIlaria Mastrorosa, Carmela Pinnetti, Anna Clelia Brita, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2021
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced diseaseYagai Bouba, Daniele Armenia, Federica Forbici, et al.
Biology of Sex Differences|November 23, 2021
Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkersMaria Teresa Pagano, Daniela Peruzzu, Luca Busani, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Antibiotics (Basel, Switzerland)|March 28, 2025
Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare SettingAssunta Navarra, Stefania Cicalini, Silvia D'Arezzo, et al.
The New Microbiologica|May 2, 2025
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics)Sara Tordi, Elena Ricci, Luca Mezzadri, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Surveillance and Characterization of Vancomycin-Resistant and Vancomycin-Variable Enterococci in a Hospital SettingClaudia Rotondo, Valentina Antonelli, Alberto Rossi, et al.
Travel Medicine and Infectious Disease|September 21, 2024
Dengue fever as autochthonous infectious disease in Italy: Epidemiological, clinical and virological characteristicsSerena Vita, Eleonora Lalle, Priscilla Caputi, et al.
Atherosclerosis|May 20, 2017
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohortPaolo Maggi, Chiara Bellacosa, Armando Leone, et al.
Journal of Fungi (Basel, Switzerland)|September 26, 2025
Pulmonary Aspergillosis in Immunocompromised Critically Ill Patients: Prevalence, Risk Factors, Clinical Features and Diagnosis-A Narrative ReviewMaria Grazia Bocci, Laura Cascarano, Giulia Capecchi, et al.
Journal of Clinical Microbiology|July 3, 2015
Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level ViremiaLavinia Fabeni, Giulia Berno, Valentina Svicher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIVIlaria Mastrorosa, Carmela Pinnetti, Anna Clelia Brita, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2021
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced diseaseYagai Bouba, Daniele Armenia, Federica Forbici, et al.
Biology of Sex Differences|November 23, 2021
Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkersMaria Teresa Pagano, Daniela Peruzzu, Luca Busani, et al.
Pageof 9